Literature DB >> 2046649

Lyme disease surveillance--United States, 1989-1990.

.   

Abstract

Surveillance for Lyme disease (LD) was initiated by CDC in 1982 (1), and in January 1991, LD became nationally reportable (2). Forty-six states reported cases in 1989 and 1990 (Figure 1), but the occurrence in nature of the causative bacterium, Borrelia burgdorferi, has not been documented in all of these states. From 1982 through 1989, the annual reported number of cases of LD increased 18-fold (from 497 to 8803, respectively) and from 1986 through 1989, nearly doubled each year (Figure 2). The provisional total of 7997 cases for 1990 suggests a plateau in this trend of rapid annual increase. This report summarizes surveillance of LD during 1990 in Connecticut, Georgia, Michigan, Missouri, New Jersey, and Wisconsin.

Entities:  

Mesh:

Year:  1991        PMID: 2046649

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  6 in total

1.  Western Blot as a confirmatory test for Lyme disease.

Authors:  H Artsob
Journal:  Can J Infect Dis       Date:  1993-03

2.  A comparison of methods for sampling the deer tick, Ixodes dammini, in a Lyme disease endemic area.

Authors:  R C Falco; D Fish
Journal:  Exp Appl Acarol       Date:  1992-05       Impact factor: 2.132

3.  Electrocardiographic findings in children with erythema migrans.

Authors:  Marija Mravljak; Tomaz Velnar; Vlado Bricelj; Eva Ruzić-Sabljić; Maja Arnez
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

4.  Identification and characterization of a surface-exposed, 66-kilodalton protein from Borrelia burgdorferi.

Authors:  W S Probert; K M Allsup; R B LeFebvre
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

Review 5.  Neuropsychological functioning in chronic Lyme disease.

Authors:  Holly James Westervelt; Robert J McCaffrey
Journal:  Neuropsychol Rev       Date:  2002-09       Impact factor: 6.940

6.  Protection against antigenically variable Borrelia burgdorferi conferred by recombinant vaccines.

Authors:  S R Telford; E Fikrig; S W Barthold; L R Brunet; A Spielman; R A Flavell
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.